|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
Z01 BC 010856
|
$12,323,380
|
Custer, Mary
|
CCR (NCI)
|
|
Continuation of follow-up of DES-exposed cohorts
|
ZIA CP010168 00020
|
$5,855,332
|
Hoover, Robert
|
DCEG (NCI)
|
|
Surgical Consultants & Collaborative Research Involving Surgical Services at NIH
|
Z01 SC 003800
|
$5,000,000
|
Rosenberg, Steven
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER SCREENING TRIAL, STUDY COORDINATI
|
N01CN025476-075
|
$4,735,521
|
O'BRIEN, BARBARA
|
WESTAT:1109753
|
|
MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM
|
5P01CA108671-03
|
$4,612,519
|
Hoffman, Ronald
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
5P01CA013106-37
|
$4,377,964
|
Hannon, Gregory
|
COLD SPRING HARBOR LABORATORY
|
|
Molecular Targets Development Program
|
Z01 BC 010469
|
$3,820,830
|
McMahon, James
|
CCR (NCI)
|
|
LABORATORY ASSESSMENT OF TOBACCO USE BEHAVIOR AND EXPOSURE TO TOXINS AMONG USERS
|
N01PC644002-004
|
$3,600,000
|
SHIELDS, PETER
|
GEORGETOWN UNIVERSITY
|
|
Radiation Oncology Branch - Radiation Clinic
|
Z01 BC 010990
|
$3,566,222
|
Camphausen, Kevin
|
CCR (NCI)
|
|
Regulatory Networks in Cancer Initiation and Progression
|
5U54CA112967-05
|
$2,680,306
|
LAUFFENBURGER, DOUGLAS
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Systems-Based Predictions of Responses to Cancer Therapy
|
5U54CA112970-05
|
$2,635,074
|
GRAY, JOE
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Branch Clinical Research Core
|
Z01 BC 010963
|
$2,448,644
|
Gress, Ronald
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER SCREENING TRIAL - SCREENING CENTER
|
N01CN025515-082
|
$2,353,493
|
YOKOCHI, LANCE
|
PACIFIC HEALTH RESEARCH INSTITUTE:111036
|
|
Multiscale Mathematical Modeling of Cancer Invasion
|
5U54CA113007-05
|
$2,313,746
|
QUARANTA, VITO
|
VANDERBILT UNIVERSITY
|
|
Translational Research in Breast Cancer
|
2P50CA058183-14
|
$2,300,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Myeloma
|
2P50CA100707-06
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
SPORE in Skin Cancer
|
1P50CA121973-01A1
|
$2,300,000
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
SPORE in Head and Neck Cancer
|
5P50CA097190-05
|
$2,184,766
|
Grandis, Jennifer
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast, ovarian and endometrial cancer in Polish women
|
Z01 CP010126-01033
|
$2,147,797
|
Brinton, Louise
|
DCEG (NCI)
|
|
Retrovirus Models of Lymphocyte Transformation and Disease
|
2P01CA100730-06
|
$2,094,373
|
Lairmore, Michael
|
OHIO STATE UNIVERSITY
|
|
Integration of Oncogenic Networks in Cancer Phenotypes
|
5U54CA112952-05
|
$2,045,871
|
NEVINS, JOSEPH
|
DUKE UNIVERSITY
|
|
SURVEILLANCE , EPIDEMIOLOGY AND END RESULTS (SEER) PROGRAM
|
N01PC544004-010
|
$1,961,142
|
CRESS, ROSEMARY
|
PUBLIC HEALTH INSTITUTE:1110113
|
|
Treatment of Infections in Immunocompromised Children
|
Z01 SC 006830
|
$1,957,171
|
Walsh, Thomas
|
CCR (NCI)
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025516-089
|
$1,929,112
|
ANDRIOLE, GERALD
|
WASHINGTON UNIV:1107522
|
|
PHASE I AND II CLINICAL TRIALS OF CHEMOPREVENTIVE AGENTS
|
N01CN035159-007
|
$1,877,000
|
LIPPMAN, SCOTT
|
University of Texas MD Anderson Cancer C
|
|
2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156732-08
|
$1,870,359
|
VISWANATH, KASISOMAYAJULA
|
DANA-FARBER CANCER INST
|
|
Immunotherapy with High Frequency, CEA Specific T Cells
|
5P01CA078673-09
|
$1,770,982
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING
|
N01CN025512-100
|
$1,710,128
|
KVALE, PAUL
|
HENRY FORD HOSPITAL:1107344
|
|
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035157-006
|
$1,704,878
|
BERGAN, RAYMOND
|
NORTHWESTERN UNIVERSITY:1107220
|
|
1/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
|
5U54CA156734-08
|
$1,691,502
|
COLON-CARMONA, ADAN
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
Genetic Analysis of the Breast Tumor Microenvironment
|
5P01CA097189-05
|
$1,677,075
|
OSTROWSKI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Software & Hardware Inference Engines for Automated Determination of Primary Cell
|
1R01CA130826-01
|
$1,671,372
|
Nolan, Garry
|
STANFORD UNIVERSITY
|
|
PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORAT
|
N01CN025404-039
|
$1,654,777
|
CHIA, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Whole Genome Scan for Modifier Genes in Colorectal Cancer
|
1R01CA126895-01A2
|
$1,643,478
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035153-009
|
$1,614,000
|
BAILEY, HOWARD
|
WISCONSIN UNIV:1107444
|
|
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
|
5P01CA067166-12
|
$1,605,434
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
CONTRACT INFORMATION SERVICE
|
N02CO511012-008
|
$1,577,675
|
HARTWELL, LELAND
|
HUTCHINSON FRED CANCER RESEARCH CTR:1106
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025513-088
|
$1,561,211
|
CHURCH, TIMOTHY
|
REGENTS OF THE UNIVERSITY OF MINNESOTA
|
|
Clinical Proteomic Technology Assessment for Cancer
|
5U24CA126479-03
|
$1,554,453
|
Liebler, Daniel
|
VANDERBILT UNIVERSITY
|
|
Assessment of serum peptide profiling to detect cancer-specific patterns
|
5U24CA126485-03
|
$1,543,596
|
TEMPST, PAUL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,540,531
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
Barr, Frederic
|
CCR (NCI)
|
|
Chemoprevention of arsenic-induced skin cancer
|
5R01CA107431-04
|
$1,511,506
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
PHASE I AND II CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
|
N01CN035158-009
|
$1,500,000
|
CHOW, SHERRY
|
ARIZONA UNIV:1109859
|
|
Temporal & spatial organization of signaling complexes in T & B Cells
|
5P01CA093615-07
|
$1,476,071
|
Koretzky, Gary
|
UNIVERSITY OF PENNSYLVANIA
|
|
Transgenic Models for Prostate and Breast Cancer
|
Z01 BC 005740
|
$1,453,669
|
Green, Jeffrey
|
CCR (NCI)
|
|
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) EXPANSION PROGRAM
|
N01PC544002-010
|
$1,440,821
|
CHEN, VIVIEN
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENI
|
N01CN025514-076
|
$1,436,604
|
CRAWFORD, DAVID
|
University Of Colorado Health Sciences C
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|